Bladogra 25 Mg 30 Tablets

Bladogra 25 Mg 30 Tablets

Description:

Bladogra xr 25 mg 30 f.c. tabs is a prescription oral medicine containing mirabegron, used for the management of overactive bladder (oab). It helps relax the bladder muscle, increase bladder capacity, and reduce symptoms such as urge urinary incontinence, urgency, and frequent urination in adults. As a health and wellness urinary tract medication, it supports better bladder control and improves quality of life for patients suffering from oab symptoms.

Indications:

• Management of overactive bladder (oab) in adults.
• Relief of symptoms associated with oab, including urge urinary incontinence (sudden leakage of urine associated with a strong need to urinate).
• Treatment of urinary urgency (sudden, compelling desire to pass urine that is difficult to defer).
• Reduction of increased urinary frequency (need to urinate more often than usual during the day and/or night).
• May be considered in patients who cannot tolerate or have inadequate response to antimuscarinic agents due to anticholinergic side effects (such as dry mouth, constipation, blurred vision).

Active Ingredients / Key Components:

• Mirabegron – 25 mg per film-coated tablet.
• Other inactive ingredients/excipients: Exact excipient list and concentrations , please check the product leaflet or the manufacturer’s official website. Refer to the package leaflet for full details.

Dosage & Administration / How to Use:

• Bladogra xr 25 mg is taken by mouth as film-coated tablets.
• Usual adult starting dose (based on mirabegron reference information): 25 mg once daily. The exact dose and any possible increase should be determined by your physician according to your condition and kidney/liver function.
• Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet, as it is an extended-release formulation.
• Can be taken with or without food, preferably at the same time each day to maintain consistent blood levels.
• Do not exceed the prescribed dose. If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Duration of use: Your doctor will determine the duration of treatment. Symptom improvement may take several weeks; continue taking the medication as prescribed even if improvement is gradual.
• Regular follow-up with your healthcare provider is recommended to assess response, monitor blood pressure, and adjust dose if needed.

Clinical Benefits:

• Helps manage overactive bladder by relaxing the detrusor muscle during the storage phase, increasing bladder capacity.
• Reduces episodes of urge urinary incontinence, helping decrease unexpected urine leakage.
• Lowers urinary urgency and frequency, supporting better bladder control throughout the day and night.
• May provide an alternative option for patients who cannot tolerate antimuscarinic medications due to anticholinergic side effects.
• Improves overall quality of life, sleep quality, and social confidence by reducing bothersome urinary symptoms.

Warnings & Contraindications:

• Use only under medical supervision. This is a prescription medicine for overactive bladder.
• Contraindicated in patients with known hypersensitivity to mirabegron or any of the excipients.
• Use with caution in patients with severe uncontrolled hypertension, as mirabegron may increase blood pressure. Blood pressure monitoring is recommended.
• Use with caution in patients with impaired kidney or liver function; dose adjustment or avoidance may be required according to severity. Your doctor will decide the appropriate regimen.
• Inform your doctor if you have a history of urinary retention, bladder outlet obstruction, or if you are taking other medications that may increase the risk of urinary retention.
• Drug interactions: Mirabegron may interact with certain medications (e.g. some beta-blockers, digoxin, certain antidepressants, and others). Always inform your healthcare provider about all medicines and supplements you are taking.
• Pregnancy and breastfeeding: Safety data in pregnancy and lactation are limited. Consult your doctor before use if you are pregnant, planning to become pregnant, or breastfeeding.
• Not recommended for use in children unless specifically prescribed by a specialist, as safety and efficacy in pediatric patients may be limited.
• Consult your doctor before use if you have heart disease, arrhythmias, liver disease, kidney disease, or uncontrolled high blood pressure.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as hypertension, liver disease, kidney disease, or heart disease.
• Not intended to diagnose, treat, cure, or prevent any disease without medical supervision; it is a prescription treatment for specific bladder conditions.
• Keep out of reach of children.

Side Effects:

• Common side effects may include increased blood pressure, urinary tract infection, headache, nasopharyngitis (cold-like symptoms), dry mouth, constipation, or dizziness.
• Less common side effects can include palpitations, tachycardia (fast heartbeat), abdominal pain, nausea, or diarrhea.
• Serious side effects (seek immediate medical attention): signs of severe allergic reaction such as rash, itching, swelling of the face, lips, or tongue, difficulty breathing; severe or sudden increase in blood pressure; chest pain; or difficulty urinating/acute urinary retention.
• If you experience persistent, bothersome, or unusual symptoms while taking Bladogra xr 25 mg, contact your healthcare provider promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the package. Store at or below the temperature specified on the outer carton (exact temperature range is not available in the provided information; refer to the product packaging).

Specifications:

• Product type: Prescription medicine for overactive bladder.
• Active ingredient: Mirabegron 25 mg per film-coated tablet.
• Form: Film-coated tablet (oral, extended-release).
• Pack size: 30 tablets per pack.
• Intended users: Adults diagnosed with overactive bladder, as directed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.